Charles Schwab Investment Management Inc Zymergen Inc. Transaction History

Charles Schwab Investment Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.2 - $3.37 $307,518 - $863,613	256,265 Added 399.52%	320,409 $891,000
Q2 2022 Aug 15, 2022	SELL	$1.12 - $3.03 $216,799 - $586,520	-193,571 Reduced 75.11%	64,144 $79,000
Q1 2022 May 13, 2022	BUY	$2.88 - $7.02 $6,053 - $14,756	2,102 Added 0.82%	257,715 $745,000
Q4 2021 Feb 11, 2022	BUY	$6.53 - $14.19 $949,670 - $2.06 Million	145,432 Added 131.99%	255,613 $1.71 Million
Q3 2021 Nov 16, 2021	SELL	$8.25 - $41.0 $50,399 - $250,469	-6,109 Reduced 5.25%	110,181 $1.45 Million
Q2 2021 Aug 16, 2021	BUY	$28.5 - $48.5 $3.31 Million - $5.64 Million	116,290 New	116,290 $4.65 Million

5.49M

Ticker ZY
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 104,355,000
Market Cap $254M
Description
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to co...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.